PLRZ•benzinga•
Polyrizon Announces The Initiation Of Preclinical Studies For Intranasal Benzodiazepines, A Treatment For Acute Repetitive Seizures And Status Epilepticus, Using Its Proprietary Drug Delivery Platform
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 25, 2025 by benzinga